Maryland · 2026 Regular Session
Providing an addition modification under the corporate income tax for the amount of certain direct-to-consumer advertising expenses for certain covered drugs paid or incurred during the taxable year that are deducted under the Internal Revenue Code; providing for the distribution of revenue attributable to the addition modification; etc.
Hearing 3/11 at 1:00 p.m. (2026-03-05)